Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 2858

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 1
Chunk 2858
---
 were effected without registration under the Securities Act in reliance on the
exemption from registration provided under Section 4(a)(2) promulgated thereunder.

In
connection with the Loan Modification Agreement, on March 22, 2023, we issued to NPIC Limited 50,000 shares of our Common Stock in exchange
for the extension of the maturity date of the loan made pursuant to the Loan and Transfer Agreement between the registrant, the Sponsor
and NPIC Limited dated December 13, 2022. These transactions were effected without registration under the Securities Act in reliance
on the exemption from registration provided under Section 4(a)(2) promulgated thereunder.

In
connection with the Loan Modification Agreement, on April 19, 2023, we issued to NPIC Limited an additional 50,000 shares of our Common
Stock in exchange for the extension of the maturity date of the loan made pursuant to the Loan and Transfer Agreement between the registrant,
the Sponsor and NPIC Limited dated December 13, 2022. These transactions were effected without registration under the Securities Act
in reliance on the exemption from registration provided under Section 4(a)(2) promulgated thereunder.

In
connection with the Loan Modification Agreement, on May 12, 2023, we issued to NPIC Limited an additional 50,000 shares of our Common
Stock in exchange for the extension of the maturity date of the loan made pursuant to the Loan and Transfer Agreement between the registrant,
the Sponsor and NPIC Limited dated December 13, 2022. These transactions were effected without registration under the Securities Act
in reliance on the exemption from registration provided under Section 4(a)(2) promulgated thereunder.

In
connection with the Marketing Services Agreement, dated March 7, 2023, between us and Outside The Box Capital (“OTBC”), we
issued to OTBC 13,257 shares of our Common Stock as consideration, pursuant to the Marketing Services Agreement, in May 2023.

In
connection with the McKra Loan Amendment, on June 5, 2023, we issued to McKra 25,000 shares of our Common Stock in exchange for the extension
of the maturity date of the loan made pursuant to the McKra Loan. These transactions were effected without registration under the Securities
Act in reliance on the exemption from registration provided under Section 4(a)(2) promulgated thereunder.

In
connection with the Second Street